DIA/FDA Statistics Forum 2014

Featured

Want to learn more about DIA/FDA Statistics Forum 2014 ? You've come to the right site!

To keep you at the forefront.

Tutorial #1:

Subgroup Analysis in Clinical Trials

Tutorial #2:

Bayesian Methods for Drug Safety Evaluation and Signal Detection

Workshop:

Dropouts from Randomized Trials in the Regulatory Environment

Tutorial #1:

Subgroup Analysis in Clinical Trials

Tutorial #2:

Bayesian Methods for Drug Safety Evaluation and Signal Detection

Workshop:

Dropouts from Randomized Trials in the Regulatory Environment

Joan Buenconsejo, PHD, MPH Head of Cardiovascular and Neuroscience Biostatistics
Bristol Myers Squibb, United States
Walter Offen, PHD Global Head of Statistical Innovation & Safety Statistics
AbbVie Inc, United States
Christy Chuang-Stein, PHD Vice President, Head of Statistical Research and Consulting Center
Chuang-Stein Consulting, LLC, United States
Brenda Crowe, PHD Associate Vice President, Statistics
Eli Lilly and Company, United States
Jose C. Pinheiro, PHD Head of Statistical Modeling and Methodology, SDS
Janssen Research & Development, LLC, United States
Estelle Russek-Cohen, PHD Senior Advisor, Office of Biostat
FDA, United States
Barry H. Schwab, PHD Vice President, Clinical Biostatistics
Janssen Research & Development, LLC, United States
Jerald Schindler, DrPH Chief Executive Officer
Strategic Statistics, United States
Ram Tiwari, PHD, MS Head of Statistical Methodology
Bristol Myres Squibb , United States
Joachim Vollmar, MSC Executive Consultant
International Clinical Development Consultants LLC (ICDC), United States
Steve Wilson, PHD Senior Staff Fellow, OB, OTS, CDER
FDA, United States